结核病脑膜炎的抗结核治疗结果:系统审查和元分析
Samin Afazel1, Mohammad J Nasiri1, Vishwanath Venketaraman2
1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
New microbes and new infections
|September 2, 2025
概括
结核性脑膜炎 (TBM) 的死亡率高 (27.7%) 和神经障碍,特别是在HIV阳性患者中. 改善诊断和治疗对于改善TBM管理的结果至关重要.
科学领域:
- 神经学
- 传染性疾病
- 公共卫生
背景情况:
- 结核性脑膜炎 (TBM) 是全球死亡和残疾的重要原因.
- 目前对TBM的治疗结果需要进一步评估以确定需要改进的领域.
研究的目的:
- 对TBM患者的抗结核药物治疗结果进行系统审查和元分析.
- 专注于评估TBM中的死亡率和神经性残疾率.
主要方法:
- 在PubMed/MEDLINE,EMBASE和Cochrane CENTRAL数据库中进行全面的文献搜索.
- 包括2005名TBM患者的10项研究,分析死亡率,神经障碍和随访损失.
- 随机效应模型用于对治疗结果的综合分析.
主要成果:
- 总体死亡率为27. 7%,艾滋病毒阳性患者 (40. 3%) 与艾滋病毒阴性患者 (17. 1%) 的死亡率明显高.
- 随访期间的损失为6. 6%. 死亡率从3个月的18. 9%增加到6个月的29. 1%.
- 使用修改的兰金尺度 (41. 7%) 报告的神经障碍的频率高于巴特尔指数 (14. 1%).
结论:
- 与高死亡率和严重的神经残疾有关,特别是在同时感染艾滋病毒的人群中.
- 标准化结果报告和新的治疗策略对于改善TBM患者的结果至关重要.
- 未来的研究应优先考虑增强的诊断工具和优化治疗方案,以减少TBM负担.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.9K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
相关概念视频
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
